Cardiology
Study: Heart-attack risk tools fail to flag nearly half of future patients
Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo
A Mount Sinai–led study finds that commonly used heart-attack risk calculators and symptom-based screening fail to identify nearly half of people who will soon experience a first heart attack. The brief report, published November 21 in JACC: Advances, underscores limitations in current prevention strategies and argues for earlier imaging to detect silent plaque.
Clínica Medilaser hosted the First Symposium on Congenital Heart Diseases “Small Hearts, Big Challenges” at the Centro de Convenciones José Eustasio Rivera, as part of launching the National HUB for Congenital Heart Diseases. The event gathered specialists to enhance early diagnosis and local treatment for these conditions in southern Colombia, aiding children from Huila and Caquetá. Experts emphasized advances in technology and a patient- and family-centered approach.
Ti AI ṣe iroyin
A large U.S. study has found that 27 percent of patients with resistant hypertension have hypercortisolism, an excess of the stress hormone cortisol. The MOMENTUM study, involving 1,086 participants across 50 centers, showed this condition is far more common than previously thought in those whose blood pressure remains high despite multiple medications. The discovery suggests screening for elevated cortisol could help explain treatment failures.